Location: Fort Smith AR, Little Rock AR, Fountain Valley CA,
Sponsor: Target PharmaSolutions, Inc.
Sex: All
Age: 0+
Code: NCT03661866
Recruiting
New
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
for
Atopic Dermatitis
Location: New Haven CT
Sponsor: Pfizer
Sex: Female
Age: 18+
Code: NCT07190430
Phase1, Recruiting
New
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Miami FL, Fargo ND
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07217015
Phase2, Recruiting
Skin Barrier Abnormalities and Oxidative Stress Response
for
Atopic Dermatitis, Food Allergy
Location: Denver CO
Sponsor: National Jewish Health
Sex: All
Age: 1 - 65
Code: NCT04606615
Recruiting
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
for
Atopic Dermatitis
Location: New York NY
Sponsor: Pfizer
Sex: Female
Age: 0+
Code: NCT05721937
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Barzolvolimab in Patients With Atopic Dermatitis
for
Atopic Dermatitis
Location: Birmingham AL, Beverly Hills CA, Burbank CA,
Sponsor: Celldex Therapeutics
Sex: All
Age: 18+
Code: NCT06727552
Phase2, Recruiting
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Birmingham AL, Peoria AZ, Phoenix AZ, Tucson AZ,
Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy